10 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents.
Institute of Materia Medica
Efficient synthesis and identification of novel propane-1,3-diamino bridged CCR5 antagonists with variation on the basic center carrier.
Institute of Materia Medica
Discovery of novel (S)-alpha-phenyl-gamma-amino butanamide containing CCR5 antagonists via functionality inversion approach.
Institute of Materia Medica
Structure-based virtual screening for identification of novel 11beta-HSD1 inhibitors.
Institute of Materia Medica
Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening.
Institute of Materia Medica
Development of l-3-aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding affinity.
Institute of Materia Medica
Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase.
Institute of Materia Medica
Synthesis and acetylcholinesterase inhibitory activity of huperzine A-E2020 combined compound.
Institute of Materia Medica
Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease.
Institute of Materia Medica